18.45 - 19.45

Pioneering pathways for 2nd-generation basal insulin use: Advancing the conversation

Evening Session

Robert Ritzel
Welcome and introduction
Rory McCrimmon
Let’s talk hypoglycemia: an under-recognized unmet need in people on basal insulin
Alice YY Cheng
Deepening the dialogue: the clinical effects of 2nd-generation basal insulins
Ronan Roussel
Beyond the current conversation: the path towards better patient care and outcomes
All faculty
Tell us more (Panel discussion)
This recorded satellite symposium specifically intended for healthcare professionals (HCPs) is sponsored by Sanofi on the occasion of the virtual EASD Annual Meeting 2020, Monday 21 September–Friday 25 September. Individual medicinal products that may be referred to during this symposium may not be authorised/licensed in all countries worldwide, please consult your local Regulatory Authority more information on individual products. Content has been developed, where applicable, consistent with the EU Summary of Product Characteristics (SmPC) valid at the time of initial presentation. Please consult prescribing information in your country of practice current to date of viewing this content, in respect to medicinal products mentioned as information may vary from country to country.
Symposium by: